Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Micro-injection-mediated hematopoietic stem cell gene therapy.

B R Davis1, D B Brown, N L Prokopishyn

  • 1University of Texas Medical Branch, Department of Microbiology and Immunology, Galveston, TX 77555, USA. brrdavis@utmb.edu

Current Opinion in Molecular Therapeutics
|March 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and family perceptions of a discharge bedside board.

PEC innovation·2023
Same author

Radioembolization with <sup>90</sup>Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy.

Cardiovascular and interventional radiology·2019
Same author

On moment of velocity for signal analysis.

Royal Society open science·2019
Same author

Radioembolization with <sup>90</sup>Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity.

Cardiovascular and interventional radiology·2019
Same author

MELD-Na score associated with postoperative complications in hernia repair in non-cirrhotic patients.

Hernia : the journal of hernias and abdominal wall surgery·2018
Same author

The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.

Journal of human hypertension·2016

Non-viral gene therapy using glass needle micro-injection shows promise for treating blood stem cell diseases. This method offers advantages over viral vectors for genetic modification and repair of gene mutations.

Area of Science:

  • Hematology
  • Gene Therapy
  • Biotechnology

Background:

  • Viral vectors (retrovirus, lentivirus, adeno-associated virus) are being developed for hematopoietic stem cell transduction.
  • Recent successes in treating X-linked severe combined immune deficiency (SCID) suggest viral approaches are viable for certain hematopoietic diseases.
  • Non-viral gene delivery methods offer significant advantages and may be essential for treating specific blood disorders.

Purpose of the Study:

  • To review non-viral gene delivery methods for blood stem cells.
  • To focus on glass needle-mediated micro-injection for genetic material delivery.
  • To highlight molecules for compensating or repairing gene mutations.

Main Methods:

  • Review of existing literature on viral and non-viral gene delivery.

Related Experiment Videos

  • Focus on glass needle micro-injection technique for hematopoietic stem cells.
  • Analysis of genetic materials for gene compensation and repair.

    • Main Results:

    • Viral vectors show promise for specific hematopoietic diseases like SCID.
    • Non-viral methods, particularly glass needle micro-injection, offer distinct advantages.
    • This technique facilitates the delivery of genetic material for therapeutic purposes.

    Conclusions:

    • Glass needle micro-injection is a viable non-viral approach for gene delivery into blood stem cells.
    • This method holds potential for treating genetic blood diseases by compensating or repairing gene defects.
    • Non-viral strategies may be crucial for advancing the treatment of various hematopoietic disorders.